PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.\', \'Department of Hematology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.\', \'Strategic Research Program on CLL, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan.\', \'Department of Medical Sciences, Hematology Section, University of Ferrara, Ferrara.\', \'Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/PPO.0000000000000535
?:doi
?:hasPublicationType
?:journal
  • Cancer journal (Sudbury, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 34398560
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now.
?:type

Metadata

Anon_0  
expand all